Literature DB >> 23881519

Regression of oral Kaposi's sarcoma after combination antiretroviral therapy.

J P S Servato1, A M Loyola, P H R Spini, T H Spini, P R de Faria, Sérgio Vitorino Cardoso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23881519     DOI： 10.1007/s15010-013-0508-x

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

Review 1.  Kaposi sarcoma: review and medical management update.

Authors:  Mahnaz Fatahzadeh
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2011-09-01

2.  Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults.

Authors:  Mhairi Maskew; A Patrick MacPhail; Denise Whitby; Matthias Egger; Matthew P Fox
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

3.  Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.

Authors:  Eileen Schneider; Suzanne Whitmore; Kathleen M Glynn; Kenneth Dominguez; Andrew Mitsch; Matthew T McKenna
Journal:  MMWR Recomm Rep       Date:  2008-12-05

4.  Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.

Authors:  Lisa L Lyons; Paula E North; Fernand Mac-Moune Lai; Mark H Stoler; Andrew L Folpe; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

5.  Microscopic diversity in oral Kaposi sarcoma.

Authors:  Belinda K Bunn; Marianne de Vasconcelos Carvalho; Melanie Louw; Pablo A Vargas; Willie F van Heerden
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-02
  5 in total
  1 in total

1.  Rapid regression of Kaposi's sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy.

Authors:  Gundolf Schüttfort; Timo Wolf; Phillip de Leuw; Gerrit Kann; Maximilian Blume; Hans-Reinhard Brodt; Christoph Stephan
Journal:  Infection       Date:  2015-05-07       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.